Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Regulations), Dr Lal Pathlabs has informed about the details of proposed schedule of Analyst/Institutional Investor meeting.
The above information is a part of company’s filings submitted to BSE.